| Daniel M. Skovronsky |
Daniel M. Skovronsky was the founder of Avid Radiopharmaceuticals, Inc. (founded in 2004) where he held the title of Chief Executive Officer. He is currently working as an Independent Director at Myriad Genetics, Inc. since 2020 and as the Chief Scientific Officer & Executive VP at Eli Lilly & Co. since 2018. He is also a Member at the University of Pennsylvania, a Member-Governance Board at the Indianapolis Museum of Art, Inc., and the President, Chief Scientific Officer & Senior VP at Lilly Research Laboratories since 2018. Dr. Skovronsky completed his doctorate degree at the University of Pennsylvania in 2000 and also holds an undergraduate degree from Yale University (1994) and a doctorate degree from Perelman School of Medicine (2001). |
| David A. Ricks |
David A. Ricks is currently the Chairman, President & Chief Executive Officer at Eli Lilly & Co. He is also the Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd., Eli Lilly Italia SpA, and the James Whitcomb Riley Children's Foundation. Additionally, he serves as an Independent Director at Adobe, Inc. and as a Director at the Pharmaceutical Research & Manufacturers of America, The Central Indiana Corporate Partnership, The Business Roundtable, and The Business Council. In his former positions, Mr. Ricks served as a Director at the European Federation of Pharmaceutical Industries & Assns. He was also a Director at Elanco Animal Health, Inc. from 2018 to 2019. Prior to that, he held positions as a Principal at HP, Inc. and International Business Machines Corp. He served as the President of the International Federation of Pharmaceutical Manufacturers. From 2009 to 2012, he was the President of Lilly USA LLC, and from 2009 to 2009, he was the President & General Manager at Lilly Industries Shanghai Ltd. He also served as the General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Mr. Ricks obtained an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990. |
| Anat Ashkenazi |
Anat Ashkenazi is currently a Director at Maravai Life Sciences, Inc. and an Independent Director at Maravai Lifesciences Holdings, Inc. She previously served as the Chief Financial Officer & Executive Vice President at Eli Lilly & Co. Ms. Ashkenazi's former positions include being an Independent Director at Varian Medical Systems, Inc., Chief Financial Officer, Controller & Senior VP at Lilly Research Laboratories, and Chief Financial Officer & VP-Finance at Lilly Diabetes. She holds an MBA from Tel-Aviv University and an undergraduate degree from The Hebrew University of Jerusalem. |
| Donald A. Zakrowski |
Donald A. Zakrowski is currently the Chief Accounting Officer & Vice President-Finance at Eli Lilly & Co. He previously worked as a Senior Manager at PricewaterhouseCoopers LLP. |
| Diogo Rau |
Diogo Rau is the founder of GiftGateway. He is currently working as the Executive VP, Chief Information & Digital Officer at Eli Lilly & Co. Prior to this, he held the position of Senior Director-Information Systems & Technology at Apple, Inc. and was a Partner at McKinsey & Co., Inc. Mr. Rau completed his undergraduate and graduate degrees at Stanford University. |
| David Hyman |
David Hyman has worked as a Chief Medical Officer at Eli Lilly & Co. since 2023 and at Loxo Oncology, Inc. since 2020. |
| Alonzo Weems |
Alonzo Weems is currently the Director at the International School of Indiana and the Director at Early Learning Indiana, Inc. He previously served as the Executive VP, Chief Ethics & Compliance Officer at Eli Lilly & Co. starting in 1997. Additionally, he is a Member-Visitor Board at Indiana University Maurer School of Law. Dr. Weems also held the position of President & Member at the Indiana Board of Law Examiners. He completed his undergraduate degree at Wabash College and obtained a doctorate from Indiana University Maurer School of Law. |
| Patrik Jonsson |
Patrik Jonsson is currently working as EVP, President-Lilly Diabetes & Obesity at Eli Lilly & Co. He previously worked as Director at The American Chamber of Commerce in Japan and as President & General Manager at Eli Lilly Italia SpA. Mr. Jonsson completed his undergraduate degree at Lund University School of Economics & Management. |
| Edgardo Hernandez |
Edgardo Hernandez is currently working as the President-Manufacturing Operations & Senior VP at Eli Lilly & Co. He started this position in 2021. Prior to his current role, he obtained a graduate degree from North Carolina State University and an undergraduate degree from the University of Puerto Rico. |
| Kimberly H. Johnson |
Kimberly H. Johnson currently works at Eli Lilly & Co., as Independent Director from 2021, Greater Washington Board of Trade, as Director, Share Our Strength, Inc., as Director, Calvert Social Investment Foundation, Inc., as Director, After-School All-Stars, as Director, Planet Works, Inc., as Director, Communities In Schools of The Nations Capital, as Director, T. Rowe Price Group, Inc., as Chief Operating Officer from 2022, and Princeton University, as Trustee. Ms. Johnson also formerly worked at Credit Suisse Group AG, as Director, Credit Suisse (USA), Inc., as Director, Federal National Mortgage Association, as Chief Operating Officer & Executive Vice President from 2018 to 2022, and D.E. Shaw & Co. LLC, as Equity Trader. Ms. Johnson received her undergraduate degree from Princeton University and Masters Business Admin degree from Columbia Business School. |
| Jon Erik Fyrwald |
Jon Erik Fyrwald currently works at International Flavors & Fragrances, Inc., as Chief Executive Officer & Director from 2024, Syngenta Crop Protection – Soluções Para A Agricultura, Ltda., as Chief Executive Officer, Syngenta Foundation For Sustainable Agriculture, as Chairman & Chief Executive Officer, and various other companies. Mr. Fyrwald also formerly worked at Nalco Co., as Chairman, President & Chief Executive Officer from 2008 to 2011, Nalco Holding Co., as Chairman, President & Chief Executive Officer in 2011, Univar NV, as President & Chief Executive Officer from 2012 to 2016, and various other companies. Mr. Fyrwald received his undergraduate degree in 1981 from the University of Delaware. |
| Juan Ricardo Luciano |
Juan Ricardo Luciano is currently the Chairman, President & Chief Executive Officer at Archer-Daniels-Midland Co. He is also the Lead Independent Director at Eli Lilly & Co. In addition, he holds director positions at Rush System for Health, The Commercial Club of Chicago, The Business Council, Kellogg School of Management, ADM Grain River System, Inc., ADM Clinton BioProcessing, Inc., Intersect Illinois, The Economic Club of Chicago, The Business Roundtable, US-China Business Council, Dow Hydrocarbons & Resources LLC, and Global Advisory Board. Mr. Luciano previously served as a Director at ADM Alliance Nutrition, Inc. and Wilmar International Ltd. He was also the President-Performance Division at The Dow Chemical Co. for a brief period. Additionally, he has held trustee positions at Boys & Girls Clubs of America and Rush University Medical Center. Mr. Luciano obtained his undergraduate degree from Instituto Tecnológico de Buenos Aires. |
| Mary Lynne Hedley |
Mary Lynne Hedley is the founder of Tesaro, Inc., which was founded in 2010, and Zycos, Inc., which was founded in 1996. She held the title of President, Chief Operating Officer & Director at Tesaro, Inc. from 2014 to 2020, and President & Chief Executive Officer at Zycos, Inc. from 1996 to 2004. Dr. Hedley currently holds the position of Independent Director at Eli Lilly & Co., Director at Helsinn Healthcare SA, Independent Director at Veeva Systems, Inc., Director at Millendo Therapeutics US, Inc., Director at Helsinn Holding SA, Director at Youville Place, Independent Non-Executive Director at Centessa Pharmaceuticals Plc, Director at Women Innovating Together In Healthcare, Venture Partner at Third Rock Ventures LLC, and is a Member of The American Association of Immunologists, American Association for the Advancement of Science, American Society of Clinical Oncology, Inc., and The American Association of Cancer Research. Her former positions include Independent Director at Receptos LLC from 2014 to 2015, Independent Director at bluebird bio, Inc. from 2017 to 2019, Independent Director at Millendo Therapeutics, Inc. from 2017 to 2021, Chief Scientific Officer & Executive VP at MGI PHARMA, Inc. from 2004 to 2008, Chief Scientific Officer & EVP-Operations at Abraxis BioScience, Inc. from 2009 to 2010, and Executive Vice President at Eisai Corp. of North America from 2008 to 2009. She also held the position of General Manager & Senior Vice President at MGI PHARMA Biologics, Inc.Dr. Hedley received her undergraduate degree from Purdue University in 1983 and her doctorate degree from The University of Texas Southwestern Medical Center in 1988. |
| Ralph Alvarez |
Ralph Alvarez's current jobs include being the Chairman at First Watch Restaurant Group, Inc., an Independent Director at Eli Lilly & Co., an Independent Director at Lowe's Companies, Inc., the Lead Independent Director at Traeger, Inc., and a Member-Presidents Council at the University of Miami School of Business. His former jobs include being the Executive Chairman at Skylark Co. Ltd., the Chairman at Skylark Holdings Co., Ltd., a Director at KeyCorp, the President, Chief Operating Officer & Director at McDonald's Corp., a Regional Director at Chipotle Mexican Grill, Inc., a Director at Anywhere Real Estate Group LLC, the Lead Independent Director at Dunkin' Brands Group, Inc., a Director at Dunkin' Brands, Inc., a Director at the National Retail Federation, Inc., a Director at The Presidents Council, a Director at Fox Cities Performing Arts Center, Inc., an Independent Director at Anywhere Real Estate, Inc., the Managing Director at Burger King España SL, a Partner at Advent International LP, the Vice President-Florida Division at Wendy's International LLC, a Budget Analyst at Burger King Corp., the President at Ronald McDonald House Charities Central West, a Trustee at The Field Museum of Natural History, the President at McDonald's USA LLC, the President at McDonald’s North America, and the President at Burger King Restaurant of Canada, Inc., and the President at McDonald's Mexico. He obtained his undergraduate degree from the University of Miami in 1976. |
| Gabrielle G. Greene-Sulzberger |
Gabrielle G. Greene-Sulzberger founded Fontis Partners LP in 2009, where she worked as General Partner from 2009 to 2017. Ms. Greene-Sulzberger also currently works at Sesame Workshop, as Chairman, True Food Kitchen Investco LLC, as Chairman from 2019, auxmoney GmbH, as Chairman, and various other companies. Ms. Greene-Sulzberger also formerly worked at Johnson Products Co., Inc., as Chief Executive Officer from 2011 to 2013, Teneo Holdings LLC, as Chairman-ESG Practice, Teneo Consulting LLC, as Chairman-ESG Practice, and various other companies. Ms. Greene-Sulzberger received her undergraduate degree in 1985 from Princeton University, Masters Business Admin degree in 1987 from Harvard Business School, graduate degree from Harvard Law School, and undergraduate degree from Woodrow Wilson School of Public & International Affairs. |
| William G. Kaelin |
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc., Cedilla Therapeutics, Inc., and Tango Therapeutics, Inc. He is currently an Independent Director at Eli Lilly & Co., Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc., Director at IconOVir Bio, Inc., Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc., Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School, and Advisor at Casdin Capital. His former positions include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member of the National Academy of Medicine (United States), Member of the American College of Physicians, Inc., and Trustee at the American Association for Cancer Research. He received his undergraduate degree from Duke University in 1982. |
| Jamere Jackson |
Jamere Jackson currently works at Eli Lilly & Co., as Independent Director from 2016, Azaa Investments, Inc., as Director, Youth Villages, Inc., as Director, Future 5, as Director, and AutoZone, Inc., as Chief Financial Officer from 2023. Mr. Jackson also formerly worked at Hibbett, Inc., as Independent Director from 2020 to 2022, First Data Corp., as Principal, GE Aerospace, as Principal from 2004 to 2014, The Hertz Corp., as Chief Financial Officer & Executive Vice President from 2018 to 2020, Procter & Gamble Co., as Principal, Total System Services, as Principal, Yum! Brands, Inc., as Principal, The Nielsen Company (US) LLC, as Chief Financial Officer, Nielsen NV, as Chief Financial Officer, Nielsen Holdings Ltd., as Chief Financial Officer from 2014 to 2018, Unison Industries LLC, as Treasurer, The Nielsen Co. BV, as Chief Financial Officer, GE Aviation Systems LLC, as Senior Executive-Finance from 2007 to 2013, Baker Hughes Energy Services LLC, as VP, Chief Financial Office-Drilling & Surface from 2013 to 2014, and Hertz Global Holdings, Inc., as Chief Financial Officer & Executive Vice President from 2018 to 2020. Mr. Jackson received his undergraduate degree in 1990 from the University of Notre Dame. |
| Katherine Baicker |
Katherine Baicker is currently an Independent Director at Eli Lilly & Co., a Trustee at Mayo Clinic, a Member of the Council on Foreign Relations, American Academy of Arts & Sciences, National Academy of Medicine, National Bureau of Economic Research, The Chicago Council on Global Affairs, National Opinion Research Center, and National Academy of Social Insurance. She is also the Dean & Professor at The University of Chicago Harris School of Public Policy and the Dean at Harris School of Public Policy Studies. Her former jobs include Chairman-Social Sciences & Population Study at National Institutes of Health, Vice Chairman at AcademyHealth, Chairman at The Group Insurance Commission, Independent Director at HMS Holdings Corp., Associate Professor & Assistant Professor at Dartmouth College, Member of Council of Economic Advisers, and Professor-Health Economics at Harvard T.H. Chan School of Public Health. She is also a former Trustee at The Urban Institute and a Member-Editorial Board at Health Affairs. Baicker received her doctorate from Harvard University and her undergraduate degree from Yale University. |
| Marschall S. Runge |
Marschall S. Runge is currently serving as an Independent Director at Eli Lilly & Co. He is also the Director at Michigan Medicine and the Director-North Carolina Translational at The University of North Carolina at Charlotte. Additionally, he holds the position of Executive Vice President-Medical Affairs & Dean at the University of Michigan. Dr. Runge is a Member of the National Institutes of Health, the American Medical Association, the American College of Cardiology Foundation, and The Association of American Medical Colleges. Formerly, Dr. Runge served as the Executive Dean & Chairman-Medicine Department at UNC School of Medicine from 2010 to 2015. He was also the Director-Cardiology & Sealy Center at the University of Texas Medical Branch, the Director-Cardiology Division at Galveston College, and a Faculty Member at The General Hospital Corp. He started his career as an Associate Professor at Emory University. Dr. Runge obtained his doctorate degree from Vanderbilt University and completed his undergraduate studies at The Johns Hopkins University School of Medicine. |
| Karen Walker |
Karen Walker is currently an Independent Director at Eli Lilly & Co., a Director at the Association of National Advertisers, Inc., an Independent Director at Sprout Social, Inc., a Director at The Munn Group, Inc., a Member at Marketers That Matter, and an Operating Partner at The Goldman Sachs Group, Inc. Previously, she held the position of Chief Marketing Officer & Senior Vice President at Cisco Systems, Inc. from 2015 to 2019, Vice President-Strategy & Marketing at HP, Inc. from 2007 to 2009, and Chief Marketing Officer & Senior Vice President at Intel Corp. from 2019 to 2023. She obtained her undergraduate degree from Loughborough University. |
